Breast adenomyoepithelioma from a radiologic perspective

Autor: Uchida, M. ^{a, ⁎}, Gatica, C. ^b, Hasson, D. ^a, Gallegos, M. ^c, Pinochet, M.Á ^a

Publikováno v: In Radiología (English Edition) March 2022 64 Supplement 1:37-43

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer.

Autor: Chakraborty S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sen U; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Ventura K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Jethalia V; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Bioinformatics for Next Generation Sequencing (BiNGS) core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Coleman C; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Bioinformatics for Next Generation Sequencing (BiNGS) core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sridhar S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Banerjee A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Ozakinci H; Department of Thoracic Oncology, Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL 33612, USA., Mahendravarman Y; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Snioch K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., de Stanchina E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shields MD; Division of Hematology/Oncology, Thoracic Oncology, IU School of Medicine, IU Health Physicians, Indianapolis, IN 46202, USA., Tomalin LE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Bioinformatics for Next Generation Sequencing (BiNGS) core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Demircioglu D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Bioinformatics for Next Generation Sequencing (BiNGS) core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Boyle TA; Department of Pathology, Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL 33612, USA., Tocheva A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Hasson D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Bioinformatics for Next Generation Sequencing (BiNGS) core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sen T; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: triparna.sen@mssm.edu.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 Dec 17; Vol. 5 (12), pp. 101852. Date of Electronic Publication: 2024 Dec 09.

Single chromatin fiber profiling and nucleosome position mapping in the human brain.

Autor: Peter CJ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Agarwal A; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Watanabe R; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Kassim BS; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Wang X; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lambert TY; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Javidfar B; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Evans V; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Dawson T; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Fridrikh M; Department of Genetics and Genomic Sciences, Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Girdhar K; Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Roussos P; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Mental Illness Research Education and Clinical Center (VISN 2 South), James J. Peters VA Medical Center, Bronx, NY 10468, USA; Center for Precision Medicine and Translational Therapeutics, James J. Peters VA Medical Center, Bronx, NY 10468, USA., Nageshwaran SK; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA., Tsankova NM; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sebra RP; Department of Genetics and Genomic Sciences, Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Vollger MR; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195, USA., Stergachis AB; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA., Hasson D; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Akbarian S; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Genetics and Genomic Sciences, Center for Advanced Genomics Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: schahram.akbarian@mssm.edu.

Publikováno v: Cell reports methods [Cell Rep Methods] 2024 Dec 16; Vol. 4 (12), pp. 100911. Date of Electronic Publication: 2024 Dec 03.

RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.

Autor: Sango J; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Carcamo S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bioinformatics for Next Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sirenko M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mansour H; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ulukaya G; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bioinformatics for Next Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Tomalin LE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bioinformatics for Next Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cruz-Rodriguez N; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wang T; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Olszewska M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Olivier E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jaud M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nadorp B; Department of Medicine, Division of Precision Medicine, NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA., Kroger B; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Medical Scientist Training Program, University of Texas Southwestern Medical Center, Dallas, TX, USA., Hu F; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Silverman L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chung SS; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA., Wagenblast E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chaligne R; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Demircioglu D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bioinformatics for Next Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Landau DA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Papaemmanuil E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hasson D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Bioinformatics for Next Generation Sequencing Shared Resource Facility, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Konopleva M; Department of Medicine (Oncology), Albert Einstein College of Medicine, Bronx, NY, USA.; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Papapetrou EP; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. eirini.papapetrou@mssm.edu.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. eirini.papapetrou@mssm.edu.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. eirini.papapetrou@mssm.edu.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. eirini.papapetrou@mssm.edu.; Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA. eirini.papapetrou@mssm.edu.

Publikováno v: Nature [Nature] 2024 Dec; Vol. 636 (8041), pp. 241-250. Date of Electronic Publication: 2024 Oct 30.

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Autor: Proteau S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Krossa I; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Husser C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Guéguinou M; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France., Sella F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Bille K; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Irondelle M; University Côte d'Azur, Nice, France., Dalmasso M; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Barouillet T; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France., Cheli Y; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Pisibon C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Arrighi N; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Nahon-Estève S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Martel A; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Gastaud L; Centre Antoine Lacassagne, Nice, France., Lassalle S; University Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France., Mignen O; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Brest P; University Côte d'Azur, Nice, France.; IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera, Nice, France., Mazure NM; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Bost F; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Baillif S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Landreville S; Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.; Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada., Turcotte S; Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.; Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada., Hasson D; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Carcamo S; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Vandier C; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France., Bernstein E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Yvan-Charvet L; University Côte d'Azur, Nice, France.; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France., Levesque MP; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Ballotti R; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Bertolotto C; University Côte d'Azur, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. Corine.Bertolotto@univ-cotedazur.fr., Strub T; University Côte d'Azur, Nice, France. thomas.strub@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. thomas.strub@univ-cotedazur.fr.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Sep; Vol. 16 (9), pp. 2262-2267.